US Stock MarketDetailed Quotes

CDXS Codexis

Watchlist
  • 3.550
  • +0.250+7.58%
Close Jul 19 16:00 ET
  • 3.510
  • -0.040-1.13%
Post 16:04 ET
250.48MMarket Cap-3776P/E (TTM)

About Codexis Company

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Company Profile

SymbolCDXS
Company NameCodexis
Listing DateApr 22, 2010
Issue Price13.00
Founded2002
CEODr. Stephen Dilly, M.B.B.S.,PhD
MarketNASDAQ
Employees174
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 Penobscot Drive
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94063-4718
Phone1-650-421-8100

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Stephen Dilly, M.B.B.S.,PhD
  • Director, President and Chief Executive Officer
  • 3.12M
  • Kevin Norrett, M.B.A.
  • Chief Operating Officer
  • 1.09M
  • Margaret Nell Fitzgerald
  • Chief Legal and Compliance Officer, General Counsel and Secretary
  • --
  • Sriram Ryali, M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • 2.78M
  • Byron L. Dorgan
  • Chairman of the Board
  • 222.75K
  • Dr. Jennifer L. Aaker, PhD
  • Independent Director
  • 160.00K
  • Dr. Esther Martinborough, PhD
  • Independent Director
  • 175.00K
  • Dr. Alison Moore, PhD
  • Independent Director
  • 190.00K
  • Dennis P. Wolf
  • Independent Director
  • 190.00K
  • David V. Smith, M.B.A.
  • Independent Director
  • 195.00K
  • Dr. Rahul Singhvi, Sc.D.
  • Independent Director
  • 196.73K
  • H. Stewart Parker
  • Independent Director
  • 180.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg